Skip to main content

Neuromuscular Disorders: Medical Treatments

Question for Department of Health and Social Care

UIN 144584, tabled on 27 January 2021

To ask the Secretary of State for Health and Social Care, if his Department will make an assessment of the potential merits of introducing specialised commissioning for therapeutic plasma exchange for neurological conditions.

This answer is the replacement for a previous holding answer.

Answered on

16 March 2021

Any decision to commission specialised interventions such as therapeutic plasma exchange (PLEX) for neurological conditions is a matter for NHS England. All decisions on treatment are made by clinical experts, informed by a patient's individual clinical needs. Wherever clinically appropriate, use of alternative therapies to immunoglobulin treatment for patients with neurological conditions, including PLEX, is stated in the current commissioning guidance which is available at the following link:

https://www.england.nhs.uk/wp-content/uploads/2019/03/PSS9-Immunoglobulin-Commissioning-Guidance-CQUIN-1920.pdf

Named day
Named day questions only occur in the House of Commons. The MP tabling the question specifies the date on which they should receive an answer. MPs may not table more than five named day questions on a single day.